Gene · 54583
Papers3,727
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,201 to 1,220 of 3,727
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A small molecule HIF-1α stabilizer that accelerates diabetic wound healing. | Nat Commun | 2021 | 34099651 | PubTator, text mining | PubMed |
| Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma. | J Exp Clin Cancer Res | 2021 | 34099013 | PubTator, text mining | PubMed |
| Congenital erythrocytosis - A condition behind recurrent thromboses: A case report and literature review. | Clin Hemorheol Microcirc | 2021 | 34092623 | PubTator, text mining | PubMed |
| Effect of Voacamine upon inhibition of hypoxia induced fatty acid synthesis in a rat model of methyln-nitrosourea induced mammary gland carcinoma. | BMC Mol Cell Biol | 2021 | 34090331 | PubTator, text mining | PubMed |
| A proximity-dependent biotinylation map of a human cell. | Nature | 2021 | 34079125 | PubTator, text mining | PubMed |
| EGFR-HIF1α signaling positively regulates the differentiation of IL-9 producing T helper cells. | Nat Commun | 2021 | 34075041 | PubTator, text mining | PubMed |
| Nicotinamide N-Methyltransferase in Acquisition of Stem Cell Properties and Therapy Resistance in Cancer. | Int J Mol Sci | 2021 | 34073600 | PubTator, text mining | PubMed |
| Cancer Cell Metabolism in Hypoxia: Role of HIF-1 as Key Regulator and Therapeutic Target. | Int J Mol Sci | 2021 | 34071836 | PubTator, text mining | PubMed |
| Distinct Concentration-Dependent Molecular Pathways Regulate Bone Cell Responses to Cobalt and Chromium Exposure from Joint Replacement Prostheses. | Int J Mol Sci | 2021 | 34069294 | PubTator, text mining | PubMed |
| Essential Role of the 14q32 Encoded miRNAs in Endocrine Tumors. | Genes (Basel) | 2021 | 34066712 | PubTator, text mining | PubMed |
Gene Expression Levels of the Prolyl Hydroxylase Domain Proteins PHD1 and PHD2 but Not PHD3 Are Decreased in Primary Tumours and Correlate with Poor Prognosis of Patients with Surgically Resected Non-Small-Cell Lung Cancer. | Cancers (Basel) | 2021 | 34065840 | PubTator, text mining | PubMed |
| Role of Hypoxia in the Control of the Cell Cycle. | Int J Mol Sci | 2021 | 34062959 | PubTator, text mining | PubMed |
| Identification of the Core MicroRNAs and Potential Molecular Mechanismsin Sarcoidosis Using Bioinformatics Analysis. | Front Mol Biosci | 2021 | 34055877 | PubTator, text mining | PubMed |
| Whole-Body Prolyl Hydroxylase Domain (PHD) 3 Deficiency Increased Plasma Lipids and Hematocrit Without Impacting Plaque Size in Low-Density Lipoprotein Receptor Knockout Mice. | Front Cell Dev Biol | 2021 | 34055796 | PubTator, text mining | PubMed |
| KSHV Reprogramming of Host Energy Metabolism for Pathogenesis. | Front Cell Infect Microbiol | 2021 | 34055662 | PubTator, text mining | PubMed |
| Are All Anti-Angiogenic Drugs the Same in the Treatment of Second-Line Metastatic Colorectal Cancer? Expert Opinion on Clinical Practice. | Front Oncol | 2021 | 34041019 | PubTator, text mining | PubMed |
| A reliable set of reference genes to normalize oxygen-dependent cytoglobin gene expression levels in melanoma. | Sci Rep | 2021 | 34035373 | PubTator, text mining | PubMed |
| Using dynamic cell communication improves treatment strategies of breast cancer. | Cancer Cell Int | 2021 | 34034721 | PubTator, text mining | PubMed |
| Inhibition of the Oxygen-Sensing Asparaginyl Hydroxylase Factor Inhibiting Hypoxia-Inducible Factor: A Potential Hypoxia Response Modulating Strategy. | J Med Chem | 2021 | 34029087 | PubTator, text mining | PubMed |
| NF-κB signalling pathways in nucleus pulposus cell function and intervertebral disc degeneration. | Cell Prolif | 2021 | 34028920 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54583/papers?page=61